β2-Glycoprotein I IgA antibodies and ischaemic stroke [8]

Rheumatology

Volumn 45, Issue 5, 2006, Pages 645-646

  Staub, Henrique L ^a   von Muhlen, C A ^a   Norman, G L ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN A ANTIBODY; AUTOANTIBODY; GLYCOPROTEIN; IMMUNOGLOBULIN A;

ANTIBODY TITER; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNITY; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; HUMAN; IMMUNOPATHOGENESIS; LETTER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOPHILIA; BLOOD; IMMUNOLOGY; NOTE;

AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN A;

EID: 33646172643     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel033     Document Type: Letter

References (3)

1. Kahles T, Humpich M, Steinmetz H, Sitzer M, Lindhoff-Last E. Phosphatidylserine IgG and beta2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke. Rheumatology 2005;44:1161-5.
2. Staub HL, Norman GL, Crowther T et al. Antibodies to the atherosclerotic plaque components beta2-glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischaemia. Arq Neuropsiquiatr 2003;61:757-63.
3. George J, Harats D, Gilburd B et al. Immunolocalization of beta2-gpI(apolipoprotein H) to human atherosclerotic plaques: Potential implications for lesion progression. Circulation 1999;99:2227-30.